These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8177121)

  • 1. Antenatal screening for neural tube defects and Down's syndrome--the importance of pretest counselling.
    Seman E
    Med J Aust; 1994 May; 160(10):658-60. PubMed ID: 8177121
    [No Abstract]   [Full Text] [Related]  

  • 2. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
    [No Abstract]   [Full Text] [Related]  

  • 3. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum screening for Down's syndrome. Counselling should emphasise possible outcomes of screening.
    Allaby M
    BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866103
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multiple of the median and its uses in antenatal screening].
    Jiangsu Province Birth Planning Commitee
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum screening for Down's syndrome. Keeping the concept of risk simple.
    Barrow M; Smith JF; Stewart C
    BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866104
    [No Abstract]   [Full Text] [Related]  

  • 9. Antenatal screening.
    Smith L
    Practitioner; 1994 Apr; 238(1537):302-9. PubMed ID: 8183817
    [No Abstract]   [Full Text] [Related]  

  • 10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for neural tube defects.
    Rajesh R; Thomas SV
    Natl Med J India; 2001; 14(6):343-6. PubMed ID: 11804365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triploid partial molar pregnancy and fetal neural tube defect detected through Down's syndrome screening.
    Quintieri F; Idotta R
    Clin Exp Obstet Gynecol; 1996; 23(3):181-3. PubMed ID: 8894330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for Down's syndrome.
    BMJ; 1991 Sep; 303(6804):715-6. PubMed ID: 1833015
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening for Down's syndrome in the second trimester].
    Goldman A; Hod M; Friedman S; Ovadia J
    Harefuah; 1991 Aug; 121(3-4):113-6. PubMed ID: 1836449
    [No Abstract]   [Full Text] [Related]  

  • 16. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
    Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
    AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
    Crossley JA; Berry E; Aitken DA; Connor JM
    Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum screening for neural tube defects and Down's syndrome.
    Med J Aust; 1991 Aug; 155(4):279-80. PubMed ID: 1831530
    [No Abstract]   [Full Text] [Related]  

  • 20. [First trimester ultrasound screening for nuchal translucency as marker of Down's syndrome].
    Herman A; Maymon R; Dreazen E; Bukovsky I; Weinraub Z
    Harefuah; 1997 Jan; 132(2):94-100. PubMed ID: 9119309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.